Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma.

Literature DB >> 10918246

False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma.

S Biasotti¹, A Garaventa, G P Villavecchia, M Cabria, M Nantron, B De Bernardi.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2000 PMID： 10918246 DOI： 10.1002/1096-911x(200008)35:2<153::aid-mpo18>3.0.co;2-7

Source DB: PubMed Journal: Med Pediatr Oncol ISSN： 0098-1532

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Authors: Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Alberto Garaventa; Luca Foppiani; Vania Altrinetti; Cristina Nanni; Pietro Bianchi; Angela Cistaro; Stefania Sorrentino; Manlio Cabria; Andrea Pession; Matteo Puntoni; Giampiero Villavecchia; Stefano Fanti
Journal: Eur J Nucl Med Mol Imaging Date: 2011-09-20 Impact factor: 9.236

2. Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.

Authors: Erin K Barr; Kathryn Laurie; Kristen Wroblewski; Mark A Applebaum; Susan L Cohn
Journal: Pediatr Blood Cancer Date: 2020-07-25 Impact factor: 3.167

3. Guidelines on nuclear medicine imaging in neuroblastoma.

Authors: Zvi Bar-Sever; Lorenzo Biassoni; Barry Shulkin; Grace Kong; Michael S Hofman; Egesta Lopci; Irina Manea; Jacek Koziorowski; Rita Castellani; Ariane Boubaker; Bieke Lambert; Thomas Pfluger; Helen Nadel; Susan Sharp; Francesco Giammarile
Journal: Eur J Nucl Med Mol Imaging Date: 2018-10 Impact factor: 9.236

4. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Authors: Henriette Ingrid Melzer; Eva Coppenrath; Irene Schmid; Michael H Albert; Dietrich von Schweinitz; Coral Tudball; Peter Bartenstein; Thomas Pfluger
Journal: Eur J Nucl Med Mol Imaging Date: 2011-05-27 Impact factor: 9.236

Review 5. 2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

Authors: John Freebody; Eva A Wegner; Monica A Rossleigh
Journal: World J Radiol Date: 2014-10-28

Review 10. Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.

Authors: Jia Xia; Hang Zhang; Qun Hu; Shuang-You Liu; Liu-Qing Zhang; Ai Zhang; Xiao-Ling Zhang; Ya-Qin Wang; Ai-Guo Liu
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2017-10-20

False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma.

1. Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

2. Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.

3. Guidelines on nuclear medicine imaging in neuroblastoma.

4. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Review 5. 2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

6. High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.

7. Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.

Review 8. Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Review 9. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Review 10. Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.